The intellectual health of clinical drug evaluation

Clinical Pharmacology and Therapeutics (1991) 50, 4–9; doi:10.1038/clpt.1991.97

[1]  R. Temple,et al.  Government Viewpoint of Clinical Trials , 1982 .

[2]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[3]  D. Salsburg.  Hypothesis versus significance testing for controlled clinical trials: a dialogue. , 1990, Statistics in medicine.

[4]  S. Green,et al.  Issues in the design of drug trials for AIDS. , 1990, Controlled clinical trials.

[5]  A. Mallet.  A maximum likelihood estimation method for random coefficient regression models , 1986 .

[6]  D. Byar,et al.  Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trials. , 1989, Controlled clinical trials.

[7]  H. Weisberg,et al.  Empirical Bayes estimation of individual growth-curve parameters and their relationship to covariates. , 1983, Biometrics.

[8]  L B Sheiner,et al.  Population dose versus response of betaxolol and atenolol: A comparison of potency and variability , 1991, Clinical pharmacology and therapeutics.

[9]  Thomas A. Louis,et al.  Empirical Bayes confidence intervals for a series of related experiments , 1989 .

[10]  N. Laird,et al.  Maximum likelihood computations with repeated measures: application of the EM algorithm , 1987 .

[11]  D. Bates,et al.  Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.

[12]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[13]  Gary O. Zerbe,et al.  On nonlinear random effects models for repeated measurements , 1991 .

[14]  F Mentré,et al.  Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics. , 1988, Biometrics.

[15]  E. Vonesh,et al.  Efficient inference for random-coefficient growth curve models with unbalanced data. , 1987, Biometrics.

[16]  R. Wit,et al.  How often is medication taken as prescribed , 1993 .

[17]  James O. Berger,et al.  Statistical Analysis and the Illusion of Objectivity , 1988 .

[18]  D. Carroll,et al.  Bromfenac, acetaminophen, and placebo in orthopedic postoperative pain , 1990, Clinical pharmacology and therapeutics.

[19]  P. Vacek,et al.  Application of a two-stage random effects model to longitudinal pulmonary function data from sarcoidosis patients. , 1989, Statistics in medicine.

[20]  C. Begg,et al.  Eligibility and extrapolation in cancer clinical trials. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  A Racine-Poon,et al.  A Bayesian approach to nonlinear random effects models. , 1985, Biometrics.

[22]  R. Jennrich,et al.  Unbalanced repeated-measures models with structured covariance matrices. , 1986, Biometrics.

[23]  L B Sheiner,et al.  Estimating population kinetics. , 1982, Critical reviews in biomedical engineering.

[24]  Robert Tibshirani,et al.  Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy , 1986 .

[25]  A. F. Smith,et al.  Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry , 1986 .

[26]  L. Braitman.  Confidence intervals extract clinically useful information from data. , 1988, Annals of internal medicine.

[27]  Norman E. Breslow,et al.  Biostatistics and Bayes , 1990 .